GlaxoSmithKline

Three momentum stocks for 2025

What if you could spot stocks early—before they become the talk of the market? Investors often chase fundamentally strong companies,…

March 28, 2025 06:02 IST

GSK launches 4 mobile dental vans in Gurgaon

The four vans were flagged off in the presence of senior leaders of the GlaxoSmithKline Asia Private Limited, along with…

Updated: November 9, 2022 21:03 IST

GSK, Pfizer, Sanofi, Zantac, cancer, health news, pharma news,

GSK’s blood cancer drug fails main trial goal, shares fall

As oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business, the company’s…

November 7, 2022 16:04 IST

The Sensodyne products are being marketed by GlaxoSmithKline (GSK) Asia in India.

Delhi HC stays DCGI order cancelling Sensodyne licence for GSK contractor

However, the bench asked the company to “ensure that no statements or advertisements which may appear in periodicals or any…

March 18, 2022 01:30 IST

US FDA, GlaxoSmithKline, Vir Biotech, COVID-19 drug, omicron

US FDA suggests restricted use of GlaxoSmithKline-Vir COVID-19 drug based on variants in circulation

The GSK-Vir drug is one of the few COVID-19 treatments shown to have worked against the original Omicron variant leading…

February 24, 2022 11:41 IST

Nifty needs to cross 17600 to reclaim 18000 levels; buy these two stocks for over 8% returns

Nifty has reached a good hurdle zone of 17600, if it manages to sustain above the said levels than 18000…

December 13, 2021 08:58 IST

Lower employee and S,G&A expenses cushioned the drop in Ebitda margin to 140 bps y-o-y.

Analyst Corner: Maintain ‘add’ on GSK Pharma with TP of Rs 1,613

Company has impaired Vemgal by Rs 1.19 billion to reflect the estimated realisable value of Rs 1.8 billion at which…

May 22, 2021 05:15 IST

Godrej Consumer Products, HUL, Sudhir Sitapati, Hindustan unilever Ltd, Q4 results

Godrej Consumer Products shares zoom 25% on HUL’s Sudhir Sitapati’s appointment as MD and CEO, Q4 results

Godrej Consumer Products share price zoomed 25 per cent to a fresh 52-week high of Rs 894 apiece intraday on…

May 12, 2021 11:38 IST

GSK Pharma rating – Add: Sale of plant to improve return ratios

Trend of recovery in acute therapies likely to continue; ‘Add’ rating retained with revised TP of Rs 1,575

April 5, 2021 02:30 IST

In a prudent decision, GSKP impaired the asset to the tune of Rs6.4bn in its Dec’20 quarterly results and was exploring all options for the plant including sale.

Analyst Corner – GlaxoSmithKline Pharma: Maintain ‘add’ with revised TP of Rs 1,575

We expect this trend in recovery in the acute therapies to continue in the coming quarters. GSKP’s exposure only to…

April 3, 2021 04:15 IST

GSK seeks lead in triple lung drug market with 2016 filing plan

The US drug filing will include clinical trials data now in hand from the closed triple combination therapy development programme,…

June 2, 2016 14:01 IST

GlaxoSmithKline posts loss as it integrates new businesses

Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker…

February 4, 2016 17:30 IST

Glenmark in agreement with Celon Pharma

Glenmark obtains semi-exclusive marketing and distribution rights for the product across 15 European countries, including Great Britain and Germany upon…

October 26, 2015 16:54 IST

Novartis acquires all remaining rights to GSK’s Ofatumumab

To develop treatments for MS and other autoimmune indications

August 21, 2015 14:49 IST

GlaxoSmithKline faces new corruption allegations, this time in Romania

Drugmaker GlaxoSmithKline , which was fined a record 3 billion yuan ($483 million) for corruption in China last year and…

July 30, 2015 12:55 IST

MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot

Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret

Updated: May 5, 2015 11:11 IST

Snapdeal beefs up its top management

Sandeep Komaravelly, who spearheaded Snapdeal’s marketing function for five years, has moved to another strategic leadership role within the company.

April 29, 2015 02:26 IST

GSK agrees UK deal for meningitis shot after Novartis stand-off

Britain will become the first country in the world to have a nationwide vaccination programme for the potentially deadly childhood…

Updated: March 30, 2015 11:35 IST

Related News

US Visa, US visa Integrity fee, H-1B, F-1 visa, tourist visas

US announces mandatory visa Integrity fee on all non-immigrant visas

US visa fees, US new visa immigration fee, ports of entry fee, new immigrant fee, Form I-94 Arrival/Departure applications

US announces new visa immigration fee for foreign nationals

3 ‘Buy’ recommendations by JM Financial, with up to 35% upside

'We have faced a 100x increase in Arattai traffic in...,' says Zoho CEO Sridhar Vembu, Perplexity AI CEO Aravind Srinivas reacts

Perplexity CEO Aravind Srinivas congratulates Sridhar Vembu as Arattai jumps from 3,000 to 350,000 sign-ups within days of its launch

After Perplexity CEO Aravind Srinivas, Radhika Gupta congratulates Zoho CEO Sridhar Vembu as WhatsApp rival Arattai sees a 100x surge in traffic

After Perplexity CEO Aravind Srinivas, Radhika Gupta congratulates Sridhar Vembu as WhatsApp rival Arattai sees a 100x surge in traffic

‘MPC likely to cut rates if external headwinds remain.’ says ICICI report

Policy8 min ago

ICICI Bank’s report suggests a possible interest rate cut by the Monetary Policy Committee in December due to external factors and slowing domestic growth. The report notes a shift in the MPC’s policy language to a more dovish tone, with external members supporting this possibility.

View all shorts

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

2 days agoSeptember 30, 2025

View All

GlaxoSmithKline

Related News

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

Trending Topics